Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122472463 | 12247246 | 3 | F | 20160823 | 20160823 | 20160407 | 20160826 | PER | PHEH2016US008305 | NOVARTIS | 86.91 | YR | M | Y | 0.00000 | 20160826 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122472463 | 12247246 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 22334 | 10 | MG | TABLET | QD | ||||||
| 122472463 | 12247246 | 2 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 3 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 4 | C | CLARITIN | LORATADINE | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 5 | C | HYDROCHLORIC ACID | HYDROCHLORIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 6 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 7 | C | OSCAL | CALCIUM CARBONATE | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 8 | C | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 122472463 | 12247246 | 9 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122472463 | 12247246 | 1 | Renal cancer |
| 122472463 | 12247246 | 2 | Product used for unknown indication |
| 122472463 | 12247246 | 3 | Product used for unknown indication |
| 122472463 | 12247246 | 4 | Product used for unknown indication |
| 122472463 | 12247246 | 5 | Product used for unknown indication |
| 122472463 | 12247246 | 6 | Product used for unknown indication |
| 122472463 | 12247246 | 7 | Product used for unknown indication |
| 122472463 | 12247246 | 8 | Product used for unknown indication |
| 122472463 | 12247246 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122472463 | 12247246 | Decreased appetite | |
| 122472463 | 12247246 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122472463 | 12247246 | 1 | 20160311 | 0 |